Proteomic analysis of purified coronavirus infectious bronchitis virus particles

Proteome Science

Volumn 8, Issue , 2010, Pages

  Kong, Qingming ^a   Xue, Chunyi ^a   Ren, Xiangpeng ^d   Zhang, Chengwen ^a   Li, Linlin ^a   Shu, Dingming ^b   Bi, Yingzuo ^c   Cao, Yongchang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b INSTITUTE OF ANIMAL SCIENCE   (China)

^c SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHAPERONE; CHROMOSOME ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; INTRACELLULAR TRAFFICKING PROTEIN; LUNG RESISTANCE PROTEIN; MACROMOLECULAR BIOSYNTHESIS PROTEIN; OVALBUMIN; PROTEIN TENP; RIBOSOME PROTEIN; SCAVENGER RECEPTOR; SIGNAL TRANSPORT PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; CELL MIGRATION; IMMUNOGOLD LABELING; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRION; VIRUS PARTICLE; WESTERN BLOTTING;

AVIAN INFECTIOUS BRONCHITIS VIRUS; CORONAVIRUS; GALLUS GALLUS;

EID: 77953223967     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-8-29     Document Type: Article

References (78)

1. Cavanagh D. Coronavirus avian infectious bronchitis virus. Vet Res 2007, 38:281-297. 10.1051/vetres:2006055, 17296157.
2. Opstelten DJ, Raamsman MJ, Wolfs K, Horzinek MC, Rottier PJ. Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol 1995, 131:339-349. 10.1083/jcb.131.2.339, 2199982, 7593163.
3. Narayanan K, Maeda A, Maeda J, Makino S. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol 2000, 74:8127-8134. 10.1128/JVI.74.17.8127-8134.2000, 112346, 10933723.
4. Xiao H, Xu LH, Yamada Y, Liu DX. Coronavirus spike protein inhibits host cell translation by interaction with eIF3f. PLoS ONE 2008, 3:e1494. 10.1371/journal.pone.0001494, 2204050, 18231581.
5. Wang J, Fang S, Xiao H, Chen B, Tam JP, Liu DX. Interaction of the coronavirus infectious bronchitis virus membrane protein with beta-actin and its implication in virion assembly and budding. PLoS One 2009, 4:e4908. 10.1371/journal.pone.0004908, 2653722, 19287488.
6. Chen CJ, An S, Makino S. Induction of apoptosis in murine coronavirus-infected 17Cl-1 cells. Adv Exp Med Biol 2001, 494:615-620.
7. An S, Chen CJ, Yu X, Leibowitz JL, Makino S. Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol 1999, 73:7853-7859. 104316, 10438879.
8. Bechtel JT, Winant RC, Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 2005, 79:4952-4964. 10.1128/JVI.79.8.4952-4964.2005, 1069574, 15795281.
9. Zhu FX, Chong JM, Wu L, Yuan Y. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol 2005, 79:800-811. 10.1128/JVI.79.2.800-811.2005, 538588, 15613308.
10. Liu HC, Soderblom EJ, Goshe MB. A mass spectrometry-based proteomic approach to study Marek's Disease Virus gene expression. J Virol Methods 2006, 135:66-75. 10.1016/j.jviromet.2006.02.001, 16563527.
11. Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, Kieff E. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci USA 2004, 101:16286-16291. 10.1073/pnas.0407320101, 528973, 15534216.
12. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 2004, 78:10960-10966. 10.1128/JVI.78.20.10960-10966.2004, 521840, 15452216.
13. Kattenhorn LM, Mills R, Wagner M, Lomsadze A, Makeev V, Borodovsky M, Ploegh HL, Kessler BM. Identification of proteins associated with murine cytomegalovirus virions. J Virol 2004, 78:11187-11197. 10.1128/JVI.78.20.11187-11197.2004, 521832, 15452238.
14. Chung CS, Chen CH, Ho MY, Huang CY, Liao CL, Chang W. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J Virol 2006, 80:2127-2140. 10.1128/JVI.80.5.2127-2140.2006, 1395410, 16474121.
15. Jensen ON, Houthaeve T, Shevchenko A, Cudmore S, Ashford T, Mann M, Griffiths G, Krijnse Locker J. Identification of the major membrane and core proteins of vaccinia virus by two-dimensional electrophoresis. J Virol 1996, 70:7485-7497. 190816, 8892867.
16. Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B. Protein composition of the vaccinia virus mature virion. Virology 2007, 358:233-247. 10.1016/j.virol.2006.08.025, 17005230.
17. Gurer C, Cimarelli A, Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol 2002, 76:4666-4670. 10.1128/JVI.76.9.4666-4670.2002, 155079, 11932435.
18. Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, Chermann JC, Henderson LE. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992, 258:1935-1938. 10.1126/science.1470916, 1470916.
19. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Sowder RC, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 2006, 80:9039-9052. 10.1128/JVI.01013-06, 1563931, 16940516.
20. Saphire AC, Gallay PA, Bark SJ. Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res 2006, 5:530-538. 10.1021/pr050276b, 16512667.
21. Segura MM, Garnier A, Di Falco MR, Whissell G, Meneses-Acosta A, Arcand N, Kamen A. Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. J Virol 2008, 82:1107-1117. 10.1128/JVI.01909-07, 2224463, 18032515.
22. Fernie BF, Gerin JL. Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion. Infect Immun 1982, 37:243-249. 347519, 7107006.
23. Mayer D, Molawi K, Martinez-Sobrido L, Ghanem A, Thomas S, Baginsky S, Grossmann J, Garcia-Sastre A, Schwemmle M. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res 2007, 6:672-682. 10.1021/pr060432u, 2577182, 17269724.
24. Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. Cellular proteins in influenza virus particles. PLoS Pathog 2008, 4:e1000085. 10.1371/journal.ppat.1000085, 2390764, 18535660.
25. Macnaughton MR, Madge MH, Davies HA, Dourmashkin RR. Polypeptides of the surface projections and the ribonucleoprotein of avian infectious bronchitis virus. J Virol 1977, 24:821-825. 516003, 201778.
26. Zeng R, Ruan HQ, Jiang XS, Zhou H, Shi L, Zhang L, Sheng QH, Tu Q, Xia QC, Wu JR. Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. J Proteome Res 2004, 3:549-555. 10.1021/pr034111j, 15253436.
27. Cantin R, Methot S, Tremblay MJ. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol 2005, 79:6577-6587. 10.1128/JVI.79.11.6577-6587.2005, 1112128, 15890896.
28. Maxwell KL, Frappier L. Viral proteomics. Microbiol Mol Biol Rev 2007, 71:398-411. 10.1128/MMBR.00042-06, 1899879, 17554050.
29. Mazzochi C, Benos DJ, Smith PR. Interaction of epithelial ion channels with the actin-based cytoskeleton. Am J Physiol Renal Physiol 2006, 291:F1113-1122. 10.1152/ajprenal.00195.2006, 16926444.
30. Sternlicht H, Farr GW, Sternlicht ML, Driscoll JK, Willison K, Yaffe MB. The t-complex polypeptide 1 complex is a chaperonin for tubulin and actin in vivo. Proc Natl Acad Sci USA 1993, 90:9422-9426. 10.1073/pnas.90.20.9422, 47580, 8105476.
31. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, Millar A, Taylor P, Bennett K, Boutilier K, Yang L, Wolting C, Donaldson I, Schandorff S, Shewnarane J, Vo M, Taggart J, Goudreault M, Muskat B, Alfarano C, Dewar D, Lin Z, Michalickova K, Willems AR, Sassi H, Nielsen PA, Rasmussen KJ, Andersen JR, Johansen LE, Hansen LH, Jespersen H, Podtelejnikov A, Nielsen E, Crawford J, Poulsen V, Sorensen BD, Matthiesen J, Hendrickson RC, Gleeson F, Pawson T, Moran MF, Durocher D, Mann M, Hogue CW, Figeys D, Tyers M. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 2002, 415:180-183. 10.1038/415180a, 11805837.
32. Kashuba E, Pokrovskaja K, Klein G, Szekely L. Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex. J Hum Virol 1999, 2:33-37.
33. Lingappa JR, Martin RL, Wong ML, Ganem D, Welch WJ, Lingappa VR. A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle. J Cell Biol 1994, 125:99-111. 10.1083/jcb.125.1.99, 2120005, 7908022.
34. Hong S, Choi G, Park S, Chung AS, Hunter E, Rhee SS. Type D retrovirus Gag polyprotein interacts with the cytosolic chaperonin TRiC. J Virol 2001, 75:2526-2534. 10.1128/JVI.75.6.2526-2534.2001, 115874, 11222675.
35. Raynor CM, Wright JF, Waisman DM, Pryzdial EL. Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry 1999, 38:5089-5095. 10.1021/bi982095b, 10213612.
36. Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N, Wild CT, Wahl SM. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 2004, 200:1337-1346. 10.1084/jem.20041115, 2211913, 15545357.
37. LeBouder F, Morello E, Rimmelzwaan GF, Bosse F, Pechoux C, Delmas B, Riteau B. Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol 2008, 82:6820-6828. 10.1128/JVI.00246-08, 2446977, 18448517.
38. Derry MC, Sutherland MR, Restall CM, Waisman DM, Pryzdial EL. Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5. J Gen Virol 2007, 88:19-27. 10.1099/vir.0.82294-0, 17170432.
39. Ryzhova EV, Vos RM, Albright AV, Harrist AV, Harvey T, Gonzalez-Scarano F. Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. J Virol 2006, 80:2694-2704. 10.1128/JVI.80.6.2694-2704.2006, 1395445, 16501079.
40. Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005, 6:449-461. 10.1038/nrm1661, 15928709.
41. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003, 60:540-551. 10.1002/jemt.10296, 12645002.
42. Lewit-Bentley A, Rety S, Sopkova-de Oliveira Santos J, Gerke V. S100-annexin complexes: some insights from structural studies. Cell Biol Int 2000, 24:799-802. 10.1006/cbir.2000.0629, 11067764.
43. Mayer MP. Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies. Rev Physiol Biochem Pharmacol 2005, 153:1-46. full_text, 15243813.
44. Maggioni C, Braakman I. Synthesis and quality control of viral membrane proteins. Curr Top Microbiol Immunol 2005, 285:175-198. full_text, 15609504.
45. Macejak DG, Luftig RB. Association of HSP70 with the adenovirus type 5 fiber protein in infected HEp-2 cells. Virology 1991, 180:120-125. 10.1016/0042-6822(91)90015-4, 1984643.
46. Macejak DG, Sarnow P. Association of heat shock protein 70 with enterovirus capsid precursor P1 in infected human cells. J Virol 1992, 66:1520-1527. 240877, 1310763.
47. Jindal S, Young RA. Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins. J Virol 1992, 66:5357-5362. 289091, 1501279.
48. Ye L, Liu Y, Yang S, Liao W, Wang C. Increased expression of Hsp70 and co-localization with nuclear protein in cells infected with the Hantaan virus. Chin Med J (Engl) 2001, 114:535-539.
49. Chappell TG, Welch WJ, Schlossman DM, Palter KB, Schlesinger MJ, Rothman JE. Uncoating ATPase is a member of the 70 kilodalton family of stress proteins. Cell 1986, 45:3-13. 10.1016/0092-8674(86)90532-5, 2937542.
50. Hu J, Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci USA 1996, 93:1060-1064. 10.1073/pnas.93.3.1060, 40030, 8577714.
51. Liu K, Qian L, Wang J, Li W, Deng X, Chen X, Sun W, Wei H, Qian X, Jiang Y, He F. Two-dimensional blue native/SDS-PAGE analysis reveals heat shock protein chaperone machinery involved in hepatitis B virus production in HepG2.2.15 cells. Mol Cell Proteomics 2009, 8:495-505. 10.1074/mcp.M800250-MCP200, 2649812, 18984579.
52. Amici C, Giorgi C, Rossi A, Santoro MG. Selective inhibition of virus protein synthesis by prostaglandin A1: a translational block associated with HSP70 synthesis. J Virol 1994, 68:6890-6899. 237124, 7933069.
53. Geller R, Vignuzzi M, Andino R, Frydman J. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 2007, 21:195-205. 10.1101/gad.1505307, 1770902, 17234885.
54. Hung JJ, Chung CS, Chang W. Molecular chaperone Hsp90 is important for vaccinia virus growth in cells. J Virol 2002, 76:1379-1390. 10.1128/JVI.76.6.2676-2682.2002, 135870, 11773412.
55. Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochem Biophys Res Commun 2007, 353:882-888. 10.1016/j.bbrc.2006.12.117, 17196931.
56. Okamoto T, Nishimura Y, Ichimura T, Suzuki K, Miyamura T, Suzuki T, Moriishi K, Matsuura Y. Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. Embo J 2006, 25:5015-5025. 10.1038/sj.emboj.7601367, 1618089, 17024179.
57. Kampmueller KM, Miller DJ. The cellular chaperone heat shock protein 90 facilitates Flock House virus RNA replication in Drosophila cells. J Virol 2005, 79:6827-6837. 10.1128/JVI.79.11.6827-6837.2005, 1112161, 15890922.
58. Momose F, Naito T, Yano K, Sugimoto S, Morikawa Y, Nagata K. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J Biol Chem 2002, 277:45306-45314. 10.1074/jbc.M206822200, 12226087.
59. Naito T, Momose F, Kawaguchi A, Nagata K. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J Virol 2007, 81:1339-1349. 10.1128/JVI.01917-06, 1797515, 17121807.
60. Connor JH, McKenzie MO, Parks GD, Lyles DS. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology 2007, 362:109-119. 10.1016/j.virol.2006.12.026, 1995422, 17258257.
61. Burch AD, Weller SK. Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J Virol 2005, 79:10740-10749. 10.1128/JVI.79.16.10740-10749.2005, 1182622, 16051866.
62. Solit DB, Chiosis G. Development and application of Hsp90 inhibitors. Drug Discov Today 2008, 13:38-43. 10.1016/j.drudis.2007.10.007, 18190862.
63. Orosz F, Wagner G, Liliom K, Kovacs J, Baroti K, Horanyi M, Farkas T, Hollan S, Ovadi J. Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules. Proc Natl Acad Sci USA 2000, 97:1026-1031. 10.1073/pnas.97.3.1026, 15510, 10655478.
64. Volker KW, Knull H. A glycolytic enzyme binding domain on tubulin. Arch Biochem Biophys 1997, 338:237-243. 10.1006/abbi.1996.9819, 9028878.
65. Volker KW, Knull HR. Glycolytic enzyme-tubulin interactions: role of tubulin carboxy terminals. J Mol Recognit 1993, 6:167-177. 10.1002/jmr.300060405, 7917412.
66. Ogino T, Yamadera T, Nonaka T, Imajoh-Ohmi S, Mizumoto K. Enolase, a cellular glycolytic enzyme, is required for efficient transcription of Sendai virus genome. Biochem Biophys Res Commun 2001, 285:447-455. 10.1006/bbrc.2001.5160, 11444863.
67. De BP, Gupta S, Zhao H, Drazba JA, Banerjee AK. Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J Biol Chem 1996, 271:24728-24735. 10.1074/jbc.271.40.24728, 8798741.
68. Petrik J, Parker H, Alexander GJ. Human hepatic glyceraldehyde-3-phosphate dehydrogenase binds to the poly(U) tract of the 3' non-coding region of hepatitis C virus genomic RNA. J Gen Virol 1999, 80(Pt 12):3109-3113.
69. Zang WQ, Fieno AM, Grant RA, Yen TS. Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element. Virology 1998, 248:46-52. 10.1006/viro.1998.9255, 9705254.
70. Yang SH, Liu ML, Tien CF, Chou SJ, Chang RY. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interaction with 3' ends of Japanese encephalitis virus RNA and colocalization with the viral NS5 protein. J Biomed Sci 2009, 16:40. 10.1186/1423-0127-16-40, 2673215, 19368702.
71. Yi M, Schultz DE, Lemon SM. Functional significance of the interaction of hepatitis A virus RNA with glyceraldehyde 3-phosphate dehydrogenase (GAPDH): opposing effects of GAPDH and polypyrimidine tract binding protein on internal ribosome entry site function. J Virol 2000, 74:6459-6468. 10.1128/JVI.74.14.6459-6468.2000, 112154, 10864658.
72. Choudhary S, De BP, Banerjee AK. Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro. J Virol 2000, 74:3634-3641. 10.1128/JVI.74.8.3634-3641.2000, 111873, 10729139.
73. Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000, 275:33053-33058. 10.1074/jbc.M005438200, 10918065.
74. Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von Eckardstein A, Assmann G. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 2006, 47:794-803. 10.1194/jlr.M500502-JLR200, 16443932.
75. Owens BJ, Anantharamaiah GM, Kahlon JB, Srinivas RV, Compans RW, Segrest JP. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J Clin Invest 1990, 86:1142-1150. 10.1172/JCI114819, 296843, 2170446.
76. Filatov FP, Sklianskaia EI. Immunoprecipitation, with an antiserum to ovalbumin, of protein NP from influenza A virus and of glycoprotein C from the herpes simplex type I virus. Vopr Virusol 1985, 30:80-86.
77. Yan RT, Wang SZ. Identification and characterization of tenp, a gene transiently expressed before overt cell differentiation during neurogenesis. J Neurobiol 1998, 34:319-328. 10.1002/(SICI)1097-4695(199803)34:4<319::AID-NEU3>3.0.CO;2-9, 9514522.
78. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, Dunn MJ. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21:3666-3672. 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6, 11271485.